Osteoporosis News and Research

Latest Osteoporosis News and Research

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.

25 Mar 2011

$Falls history improves accuracy of fracture prediction models$

Falls history improves accuracy of fracture prediction models

Researchers from the MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented a new study that shows how the inclusion of falls history, in addition to clinical risk factors (CRFs) and bone mineral density (BMD) values, would greatly improve the accuracy of fracture prediction models. The research findings were presented today at the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain.

25 Mar 2011

$ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro$

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs.

25 Mar 2011

Electromagnetic radiation from cellular phones may affect bone strength

Electromagnetic radiation from cellular phones may adversely affect bone strength, suggests a study in the March Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Mar 2011

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

25 Mar 2011

Experts to present latest advances in bone research at annual European meeting

Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.

24 Mar 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

$Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty$

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.

23 Mar 2011

Breast cancer updates

Many survivors of breast cancer cite stress as a link to the cancer despite no scientific proof of a connection. Experts believe that the root cause here are the lifestyle-related issues - such as smoking and obesity - where there is a clear link to the cancer.

22 Mar 2011

IOF, Fonterra Brands award 10,000 USD to OSPFI for Bone Health Campaign

The Osteoporosis Society of the Philippines Foundation Inc was awarded the first IOF-Anlene Nutrition Awareness for Bone Health Campaign Grant at a presentation ceremony that took place at the IOF World Wide Conference of Osteoporosis Patient Societies in Valencia, Spain on March 20, 2011.

22 Mar 2011

EDMA endorses the campaign against excessive use of salt

EDMA, the European Diagnostic Manufacturers Association, fully endorses the 2011 World Salt Awareness Week theme “Salt and Men’s Health” as the latter reminds that more men than women die prematurely of cardiovascular diseases (CVD).

21 Mar 2011

Patient society representatives gather to discuss new strategies to fight osteoporosis

Today, more than 130 osteoporosis patient society representatives gathered in Valencia, Spain for the opening of the 13th IOF World Wide Conference of Osteoporosis Patient Societies.

19 Mar 2011

Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs

Every Friday, Jennifer Evans compiles this selection of recently-released health policy studies and briefs.

19 Mar 2011

Springer editor receives ERC Advanced Grants for biosilicate research

The European Research Council has awarded one of this year's ERC Advanced Grants to Springer editor Dr. Werner M-ller, thus supporting his well-established research in the field of biosilicates with prize money of 2.2 million euros.

19 Mar 2011

Unigene initiates oral PTH Phase 2 study in postmenopausal women with osteoporosis

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the dosing of the first subject in a Phase 2 study with an experimental oral parathyroid hormone analog for the treatment of osteoporosis in postmenopausal women.

16 Mar 2011

Researchers receive NIH grant to study effects of BBTW treatment in patients with MS

Motion Therapeutics, Inc., the leading provider of noninvasive therapeutic solutions for balance and mobility disorders, today announced that researchers at Samuel Merritt University and San Francisco State received a NIH Recovery Act Grant to study the effects of wearing a strategically weighted vest to improve gait and mobility in people with MS.

15 Mar 2011

New research: Fzd9 receptor can stimulate bone formation

New research shows that the Wnt receptor Frizzled-9 promotes bone formation, providing a potential new target for the treatment of osteoporosis. The study appears online on March 14 in The Journal of Cell Biology.

15 Mar 2011

SOM Biotech closes first financing round and files patent application

SOM Biotech, a biopharmaceutical start-up company with a business model centered on the identification and development of drug repurposing opportunities, reports significant progress on its trajectory towards pipeline development and candidate outlicensing.

14 Mar 2011

CWRU: Postmenopausal women need more dental checkups

Postmenopausal women have a new health message to hear. Two annual dental checkups aren't enough. Older women need more, according to research findings from the Case Western Reserve University School of Dental Medicine and the Cleveland Clinic.

11 Mar 2011

Osteoporosis News and Research

Latest Osteoporosis News and Research

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Falls history improves accuracy of fracture prediction models

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Electromagnetic radiation from cellular phones may affect bone strength

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Experts to present latest advances in bone research at annual European meeting

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Breast cancer updates

IOF, Fonterra Brands award 10,000 USD to OSPFI for Bone Health Campaign

EDMA endorses the campaign against excessive use of salt

Patient society representatives gather to discuss new strategies to fight osteoporosis

Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs

Springer editor receives ERC Advanced Grants for biosilicate research

Unigene initiates oral PTH Phase 2 study in postmenopausal women with osteoporosis

Researchers receive NIH grant to study effects of BBTW treatment in patients with MS

New research: Fzd9 receptor can stimulate bone formation

SOM Biotech closes first financing round and files patent application

CWRU: Postmenopausal women need more dental checkups

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Osteoporosis News and Research

Latest Osteoporosis News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in